Related Experiment Videos
Pathways for degradation of connexins and gap junctions
Viviana M Berthoud1, Peter J Minogue, James G Laing
1Department of Pediatrics, Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave., MC 4060, Chicago, IL 60637, USA. vberthou@peds.bsd.uchicago.edu
Cardiovascular Research
|April 20, 2004
Summary
Connexins, the proteins forming gap junctions, are rapidly degraded. Three pathways involving the proteasome and lysosome explain connexin degradation, influenced by cell type and regulatory signals.
Area of Science:
- Cell Biology
- Protein Degradation
- Membrane Biology
Background:
- Gap junctional proteins, connexins, and their plaques have short half-lives.
- Understanding connexin turnover is crucial for cellular communication and tissue homeostasis.
Purpose of the Study:
- To elucidate the degradation pathways of connexins and gap junctional plaques.
- To identify regulatory mechanisms governing connexin turnover.
Main Methods:
- Review of proposed degradation pathways for connexins.
- Analysis of proteasomal and lysosomal degradation routes.
- Consideration of regulatory factors like ubiquitinylation and phosphorylation.
Main Results:
- Three primary degradation pathways exist: ER-associated degradation via proteasome, direct lysosomal targeting from early secretory compartments, and lysosomal degradation post-endocytosis.
- Degradation can be proteasome-dependent in certain cell types.
- Ubiquitinylation, phosphorylation, and specific polypeptide domains act as regulatory sorting signals.
Conclusions:
- Connexin degradation is a complex, multi-pathway process involving both the proteasome and lysosome.
- Cell type and regulatory signals significantly influence the specific degradation route utilized.
- These findings provide insights into the dynamic regulation of gap junction function.